Home › Compare › NXOPF vs BTI

NXOPF vs BTI: Dividend Comparison 2026

NXOPF yields 100000.00% · BTI yields 5.38%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NXOPF wins by $4.832206901976048e+26M in total portfolio value
10 years
NXOPF
NXOPF
● Live price
100000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.832206901976048e+26M
Annual income
$482,271,988,201,431,700,000,000,000,000,000.00
Full NXOPF calculator →
BTI
BTI
● Live price
5.38%
Share price
$58.47
Annual div
$3.15
5Y div CAGR
11.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.7K
Annual income
$2,786.64
Full BTI calculator →

Portfolio growth — NXOPF vs BTI

📍 NXOPF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNXOPFBTI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NXOPF + BTI cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
NXOPF pays
BTI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NXOPF
Annual income on $10K today (after 15% tax)
$8,500,000.00/yr
After 10yr DRIP, annual income (after tax)
$409,931,189,971,216,900,000,000,000,000,000.00/yr
BTI
Annual income on $10K today (after 15% tax)
$457.40/yr
After 10yr DRIP, annual income (after tax)
$2,368.64/yr
At 15% tax rate, NXOPF beats the other by $409,931,189,971,216,900,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NXOPF + BTI for your $10,000?

NXOPF: 50%BTI: 50%
100% BTI50/50100% NXOPF
Portfolio after 10yr
$2.416103450988024e+26M
Annual income
$241,135,994,100,715,840,000,000,000,000,000.00/yr
Blended yield
99.80%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

NXOPF
No analyst data
Altman Z
-1690.8
Piotroski
1/9
BTI
Analyst Ratings
12
Buy
4
Hold
2
Sell
Consensus: Buy
Price Target
$40.00
-31.6% upside vs current
Range: $40.00 — $40.00
Altman Z
2.1
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NXOPF buys
0
BTI buys
0
No recent congressional trades found for NXOPF or BTI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNXOPFBTI
Forward yield100000.00% ✓5.38%
Annual dividend / share$2.00$3.15 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%11.3% ✓
Portfolio after 10y$4.832206901976048e+26M$37.7K ✓
Annual income after 10y$482,271,988,201,431,700,000,000,000,000,000.00 ✓$2,786.64
Total dividends collected$4.8315851896727036e+26M$14.3K ✓
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: NXOPF vs BTI ($10,000, DRIP)

YearNXOPF PortfolioNXOPF Income/yrBTI PortfolioBTI Income/yrGap
1← crossover$10,010,700$10,000,000.00$11,299$598.92+$10.00M → NXOPF
2$9,366,505,842$9,355,794,392.52$12,794$703.91+$9366.49M → NXOPF
3$8,191,091,111,834$8,181,068,950,583.78$14,518$829.07+$8191091.10M → NXOPF
4$6,695,134,751,499,451$6,686,370,284,009,789.00$16,513$978.64+$6695134751.48M → NXOPF
5$5,114,850,040,116,031,000$5,107,686,245,931,928,000.00$18,827$1,157.84+$5114850040116.01M → NXOPF
6$3,652,290,278,277,141,000,000$3,646,817,388,734,216,400,000.00$21,518$1,373.12+$3652290278277141.00M → NXOPF
7$2,437,583,176,648,375,000,000,000$2,433,675,226,050,619,000,000,000.00$24,657$1,632.46+$2437583176648375296.00M → NXOPF
8$1,520,612,508,079,010,700,000,000,000$1,518,004,294,079,997,000,000,000,000.00$28,329$1,945.74+$1.5206125080790106e+21M → NXOPF
9$886,637,379,601,106,600,000,000,000,000$885,010,324,217,461,900,000,000,000,000.00$32,637$2,325.33+$8.866373796011065e+23M → NXOPF
10$483,220,690,197,604,800,000,000,000,000,000$482,271,988,201,431,700,000,000,000,000,000.00$37,708$2,786.64+$4.832206901976048e+26M → NXOPF

NXOPF vs BTI: Complete Analysis 2026

NXOPF — Stock

NexOptic Technology Corp., a technology company, develops and invests in optical and lens technologies. It engages in developing All Light Intelligent Imaging Solutions (ALIIS), a suite of intelligent imaging solution that processes raw images and video in real time; and DoubleTake, a wide-angle and telephoto camera that allow near-instant spotting and zooming capabilities. The company was formerly known as Elissa Resources Ltd. and changed its name to NexOptic Technology Corp. in February 2016. NexOptic Technology Corp. was incorporated in 2007 and is headquartered in Vancouver, Canada.

Full NXOPF Calculator →

BTI — Consumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →
📬

Get this NXOPF vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NXOPF vs SCHDNXOPF vs JEPINXOPF vs ONXOPF vs KONXOPF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.